FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2906223012> ?p ?o ?g. }

• W2906223012 endingPage "e0197671" @default.
• W2906223012 startingPage "e0197671" @default.
• W2906223012 abstract "Background We developed and tested the effectiveness of a tailored health information technology driven intervention: “Talking Prescriptions” (Talking Rx) to improve medication adherence in a resource challenged environment. Methods We conducted a parallel, randomized, controlled, assessor-blinded trial at the Aga Khan University (AKU), Karachi, Pakistan. Adults with diagnosis of cerebrovascular accident (CVA) or coronary artery disease (CAD) diagnosed least one month before enrollment, on anti-platelets and statins, with access to a mobile phone were enrolled. The intervention group received a) Daily Interactive Voice Response (IVR) call services regarding specific statin and antiplatelet b) Daily tailored medication reminders for statin and antiplatelet and c) Weekly lifestyle modification messages for a period of 3 months. We assessed Medication adherence to statin and antiplatelets by a validated version of the 8-item Morisky Medication Adherence scale 8 (MMAS-8) at 3 months by a blinded assessment officer. Analysis was conducted by intention-to-treat principle (ITT). Results Between April 2015 and December 2015, 197 participants (99 in intervention and 98 in the usual care group) enrolled in the Talking Rx Study. The dropout rate was 9.6%. Baseline group characteristics were similar. At baseline, the mean MMAS-8 was 6.68 (SD = 1.28) in the intervention group and 6.77 (SD = 1.36) in usual care group. At end of follow-up, the mean MMAS-8 increased to 7.41(0.78) in the intervention group compared with 7.38 (0.99) in usual care group with mean difference of 0.03 (S.D 0.13) (95% C.I [-0.23, 0.29]), which was not statistically significant. (P-Value = 0.40) CVA patients showed a relatively greater magnitude of adherence via the MMAS-8 at the end of follow up where the mean MMAS-8 increased to 7.29 (S.D 0.82) in the intervention group as compared to 7.07(S.D 1.24) in usual care group with mean difference of 0.22 (SD = 0.22) 95% C.I (-0.20, 0.65) with (P-value = 0.15). Around 84% of those on intervention arm used the service, calling at least 3 times and listening to their prescriptions for an average of 8 minutes. No user was excluded due to technologic reasons. Conclusion The use of a phone based medication adherence program was feasible in LMIC settings with high volume clinics and low patient literacy. In this early study, with limited follow up, the program did not achieve any statistically significant differences in adherence behavior as self—reported by the MMAS-8 Scale. Trial registration Clinical Trials.gov NCT02354040." @default.
• W2906223012 created "2019-01-01" @default.
• W2906223012 creator A5005137106 @default.
• W2906223012 creator A5010041931 @default.
• W2906223012 creator A5012108828 @default.
• W2906223012 creator A5012603783 @default.
• W2906223012 creator A5014486053 @default.
• W2906223012 creator A5019178293 @default.
• W2906223012 creator A5023464716 @default.
• W2906223012 creator A5023689769 @default.
• W2906223012 creator A5037849442 @default.
• W2906223012 creator A5043672751 @default.
• W2906223012 creator A5048832333 @default.
• W2906223012 creator A5052266911 @default.
• W2906223012 creator A5058860610 @default.
• W2906223012 creator A5059498606 @default.
• W2906223012 creator A5065743406 @default.
• W2906223012 creator A5070844064 @default.
• W2906223012 creator A5071432256 @default.
• W2906223012 creator A5073710297 @default.
• W2906223012 creator A5076109851 @default.
• W2906223012 date "2018-12-20" @default.
• W2906223012 modified "2023-09-26" @default.
• W2906223012 title "Making prescriptions “talk” to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study)" @default.
• W2906223012 cites W1845225129 @default.
• W2906223012 cites W1854618833 @default.
• W2906223012 cites W1966242613 @default.
• W2906223012 cites W1991495732 @default.
• W2906223012 cites W1999377006 @default.
• W2906223012 cites W2013620493 @default.
• W2906223012 cites W2031921142 @default.
• W2906223012 cites W2032356841 @default.
• W2906223012 cites W2044103814 @default.
• W2906223012 cites W2054796764 @default.
• W2906223012 cites W2080461766 @default.
• W2906223012 cites W2081288128 @default.
• W2906223012 cites W2108361166 @default.
• W2906223012 cites W2108696783 @default.
• W2906223012 cites W2119134819 @default.
• W2906223012 cites W2130253452 @default.
• W2906223012 cites W2153360349 @default.
• W2906223012 cites W2158216255 @default.
• W2906223012 cites W2168349040 @default.
• W2906223012 cites W2290500397 @default.
• W2906223012 cites W2300936160 @default.
• W2906223012 cites W2336336756 @default.
• W2906223012 doi "https://doi.org/10.1371/journal.pone.0197671" @default.
• W2906223012 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6301764" @default.
• W2906223012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30571697" @default.
• W2906223012 hasPublicationYear "2018" @default.
• W2906223012 type Work @default.
• W2906223012 sameAs 2906223012 @default.
• W2906223012 citedByCount "16" @default.
• W2906223012 countsByYear W29062230122020 @default.
• W2906223012 countsByYear W29062230122021 @default.
• W2906223012 countsByYear W29062230122022 @default.
• W2906223012 countsByYear W29062230122023 @default.
• W2906223012 crossrefType "journal-article" @default.
• W2906223012 hasAuthorship W2906223012A5005137106 @default.
• W2906223012 hasAuthorship W2906223012A5010041931 @default.
• W2906223012 hasAuthorship W2906223012A5012108828 @default.
• W2906223012 hasAuthorship W2906223012A5012603783 @default.
• W2906223012 hasAuthorship W2906223012A5014486053 @default.
• W2906223012 hasAuthorship W2906223012A5019178293 @default.
• W2906223012 hasAuthorship W2906223012A5023464716 @default.
• W2906223012 hasAuthorship W2906223012A5023689769 @default.
• W2906223012 hasAuthorship W2906223012A5037849442 @default.
• W2906223012 hasAuthorship W2906223012A5043672751 @default.
• W2906223012 hasAuthorship W2906223012A5048832333 @default.
• W2906223012 hasAuthorship W2906223012A5052266911 @default.
• W2906223012 hasAuthorship W2906223012A5058860610 @default.
• W2906223012 hasAuthorship W2906223012A5059498606 @default.
• W2906223012 hasAuthorship W2906223012A5065743406 @default.
• W2906223012 hasAuthorship W2906223012A5070844064 @default.
• W2906223012 hasAuthorship W2906223012A5071432256 @default.
• W2906223012 hasAuthorship W2906223012A5073710297 @default.
• W2906223012 hasAuthorship W2906223012A5076109851 @default.
• W2906223012 hasBestOaLocation W29062230121 @default.
• W2906223012 hasConcept C118552586 @default.
• W2906223012 hasConcept C126322002 @default.
• W2906223012 hasConcept C127413603 @default.
• W2906223012 hasConcept C159110408 @default.
• W2906223012 hasConcept C168563851 @default.
• W2906223012 hasConcept C1862650 @default.
• W2906223012 hasConcept C2426938 @default.
• W2906223012 hasConcept C2776839432 @default.
• W2906223012 hasConcept C2780645631 @default.
• W2906223012 hasConcept C2780665704 @default.
• W2906223012 hasConcept C3018553135 @default.
• W2906223012 hasConcept C535046627 @default.
• W2906223012 hasConcept C71924100 @default.
• W2906223012 hasConcept C78519656 @default.
• W2906223012 hasConceptScore W2906223012C118552586 @default.
• W2906223012 hasConceptScore W2906223012C126322002 @default.
• W2906223012 hasConceptScore W2906223012C127413603 @default.
• W2906223012 hasConceptScore W2906223012C159110408 @default.
• W2906223012 hasConceptScore W2906223012C168563851 @default.
• W2906223012 hasConceptScore W2906223012C1862650 @default.

• next